- Home
- CHRS vs JEQ Comparison
CHRS vs JEQ Comparison
Compare CHRS & JEQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- JEQ
- Stock Information
- Founded
- CHRS 2010
- JEQ 1990
- Country
- CHRS United States
- JEQ United States
- Employees
- CHRS N/A
- JEQ N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- JEQ Air Freight/Delivery Services
- Sector
- CHRS Health Care
- JEQ Consumer Discretionary
- Exchange
- CHRS Nasdaq
- JEQ Nasdaq
- Market Cap
- CHRS 94.0M
- JEQ 90.2M
- IPO Year
- CHRS 2014
- JEQ N/A
- Fundamental
- Price
- CHRS $0.91
- JEQ $6.42
- Analyst Decision
- CHRS Strong Buy
- JEQ
- Analyst Count
- CHRS 4
- JEQ 0
- Target Price
- CHRS $5.38
- JEQ N/A
- AVG Volume (30 Days)
- CHRS 2.1M
- JEQ 32.0K
- Earning Date
- CHRS 05-08-2025
- JEQ 01-01-0001
- Dividend Yield
- CHRS N/A
- JEQ 7.05%
- EPS Growth
- CHRS N/A
- JEQ N/A
- EPS
- CHRS 0.25
- JEQ N/A
- Revenue
- CHRS $266,959,999.00
- JEQ N/A
- Revenue This Year
- CHRS N/A
- JEQ N/A
- Revenue Next Year
- CHRS $9.02
- JEQ N/A
- P/E Ratio
- CHRS $3.66
- JEQ N/A
- Revenue Growth
- CHRS 3.78
- JEQ N/A
- 52 Week Low
- CHRS $0.66
- JEQ $4.99
- 52 Week High
- CHRS $2.61
- JEQ $6.39
- Technical
- Relative Strength Index (RSI)
- CHRS 45.16
- JEQ 53.62
- Support Level
- CHRS $0.89
- JEQ $6.65
- Resistance Level
- CHRS $1.07
- JEQ $6.76
- Average True Range (ATR)
- CHRS 0.09
- JEQ 0.09
- MACD
- CHRS -0.00
- JEQ -0.04
- Stochastic Oscillator
- CHRS 44.79
- JEQ 16.90
About CHRS Coherus BioSciences Inc.
Coherus BioSciences Inc is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of innovative immunotherapies to treat cancer. Coherus is developing an innovative immuno-oncology pipeline which includes multiple antibody immunotherapy candidates focused on enhancing the innate and adaptive immune responses to enable a robust antitumor immunologic response and enhance outcomes for patients with cancer.
About JEQ abrdn Japan Equity Fund Inc.
Aberdeen Japan Equity Fund Inc is a United States-based closed-end diversified management investment company. Its investment objective is to outperform over the long term, on a total return basis (including appreciation and dividends), the Tokyo Stock Price Index ("TOPIX"). The fund seeks to achieve its investment objective by investing a majority of its assets, in equity securities of companies listed on the Tokyo Stock Exchange or listed on the over-the-counter market in Japan or listed on other stock exchanges in Japan. The portfolio of investments is spread across Consumer Discretionary, Industrials, Information Technology, Financials, and other sectors.